Clinical trial
Dose-Exposure-Response in Type 1 Diabetes Mellitus
NCT00368394 · Sanofi, Industry · Completed
Key facts
| NCT number | NCT00368394 |
|---|---|
| Title | Dose-Exposure-Response in Type 1 Diabetes Mellitus |
| Official title | Dose-Exposure-Response Relationship of Insulin Glulisine (HMR1964) in Subjects With Type 1 Diabetes Mellitus Assessed With the Euglycemic Clamp Technique Using the Biostator (TM) |
| Lead sponsor | Sanofi, Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Diabetes Mellitus, Type I |
| Intervention type | Drug |
| Interventions | Insulin glulisine |
| Enrollment | 18 |
| Start date | Jan 1, 2004 |
| First posted | Aug 24, 2006 |
| Last update posted | Aug 24, 2006 |
| Countries | Germany |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: